Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GYRE · against 394 other Healthcare companies of similar size
Ranked #285 of 395 · scores higher than 26% of peers
Bars: peers in each 10-point band of the growth score62 peers with a growth score of 10–19, including GYRE · Click a bar to see the companies
Mainly because of its earnings per share growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | GYRE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 409 reported | -3.4% | 3.1% | 33% | 33% | |
| Earnings per share growthHigher is better · 201 reported | -60.0% | 4.6% | 12% | 33% | |
| 3-year revenue growthHigher is better · 387 reported | 4.5% | 3.2% | 53% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 5 | 3.9B HKD (≈$493M) | 98 | 66 | |
| 285 | 4.7B HKD (≈$606M) | 18 | 75 | |
| 285 | 2.1B CNY (≈$295M) | 18 | 39 | |
| 285 | 1.4B MYR (≈$309M) | 18 | 31 | |
| 285 | 222M GBP (≈$288M) | 18 | 13 | |
| 285 | 471M USD | 18 | 21 | |
| 285 | 474M USD | 18 | 46 | |
| 285 | 471M NZD (≈$282M) | 18 | 23 | |
| 285 | 528M USD | 18 | 58 | |
| 295 | 1.9B CNY (≈$270M) | 17 | 17 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score